肺结核
药品
结核分枝杆菌
抗药性
金标准(测试)
医学
限制
重症监护医学
生物
药理学
微生物学
内科学
病理
机械工程
工程类
作者
Thi Ngoc Anh Nguyen,Véronique Anton-Le Berre,Anne‐Laure Bañuls,Thi Van Anh Nguyen
标识
DOI:10.3389/fmicb.2019.00794
摘要
Drug-resistant tuberculosis is a global health problem that hinders the progress of tuberculosis eradication programs. Accurate and early detection of drug-resistant tuberculosis is essential for effective patient care, for preventing tuberculosis spread, and for limiting the development of drug-resistant strains. Culture-based drug susceptibility tests are the gold standard method for the detection of drug-resistant tuberculosis, but they are time-consuming and technically challenging, especially in low- and middle-income countries. Nowadays, different nucleic acid-based assays that detect gene mutations associated with resistance to drugs used to treat tuberculosis are available. These tests vary in type and number of targets and in sensitivity and specificity. In this review, we will describe the available molecular tests for drug-resistant tuberculosis detection and discuss their advantages and limitations.
科研通智能强力驱动
Strongly Powered by AbleSci AI